Condivisione di buoni prodotti della Rete.
Contributed by Mauro Magnani
Le nuove tribù promuovono nuove infrastrutture di accesso alla Rete. L'innovazione la promuovono i Cittadini; siamo noi quelli che stiamo aspettando.
Prize4Life is seeking a biomarker for measuring disease progression in Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s Disease). The proposed biomarker should meet the criteria outlined in the Detailed Description & Requirements of the challenge. Up to 1 million USD will be awarded for a validated ALS biomarker capable of being used in Phase II clinical trials to determine treatment efficacy. Any biological correlate (e.g. body fluids, imaging, electrophysiological examination etc.) can qualify as a solution, as long as the Solver provides a detailed description and validation for it. There are no specific requirements as to the method by which the Solver delivers a result. As an example, the validation could be based on clinical or experimental work, or on statistical analysis of existing trials data. However, the Solver must provide statistically significant results as proof for the validity of the solution. All biological correlate(s) need to be thoroughly characterized. The Solver's proposal should also be accompanied by a solid scientific rationale supported by literature precedents. If Solvers are facing difficulties getting access to necessary information, they can approach the Seeker. The Seeker will help if he sees fit to do so. The deadline for this prize is rolling such that submissions will be considered as they are received and, at the discretion of the Seeker, the first submission which meets all of the challenge criteria will be awarded the prize. Unlike many other InnoCentive Seekers, Prize4Life makes no IP claims as to the solution submitted and our IP policy is explained in more detail in the solver agreement.
InnoCentive is the global innovation marketplace where creative minds solve some of the world's most important problems for cash awards up to $1 million. Commercial, governmental and humanitarian organizations engage with InnoCentive to solve problems that can impact humankind in areas ranging from the environment to medical advancements.
An InnoCentive RTP (Reduction to Practice) Challenge is a prototype that proves an idea, and is similar to an InnoCentive Theoretical Challenge in its high level of detail. However, an RTP requires the Solver to submit a validated solution, either in the form of original data or a physical sample. Also the Seeker is allowed to test the proposed solution.
Exclusive rights to the Intellectual Property are always transferred to the Seeker in an RTP Challenge.